Cardiac resynchronization therapy in heart failure patients: An update

Cardiology Journal

Volumn 16, Issue 3, 2009, Pages 197-209

  Jeevanantham, Vinodh ^a   Daubert, James P ^b   Zareba, Wojciech ^b  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cardiac resynchronization therapy; Heart failure; Review

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; IMPLANTATION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; QRS COMPLEX; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE; CARDIOVERSION; CONVALESCENCE; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; INSTRUMENTATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; QUALITY OF LIFE; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 67650470589     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. http://www.cdc.gov/dhdsp/library/pdfs/fs_heart_failure.pdf
2. American Heart Association. Heart Disease and Stroke Facts, 2006 Update. Dallas, Texas: AHA, 2006.
3. Kinsella K, Velkoff VA. An aging world 2001 (http://www.census.gov/ prod/2001pubs/p95-01-1.pdf).
4. Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA, 2004; 292: 344-350.
5. Administration of aging: Statistics of aging (http://www.aoa.gov//prof/ Statistics/statistics.asp).
6. Jessup M, Brozena S. Medical progress. Heart failure. NEJM, 2003; 348: 2007-2018.
7. Donal E, Leclercq C, Linde C, Daubert JC. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J, 2006; 27: 1018-1025.
8. The SOLVED Investigators. Effect of enalapril on survival in patients with reduced LV ejection fraction and congestive heart failure. NEJM, 1991; 325: 293-302.
9. COSENSUS. Effects of enalapril on mortality in severe congestive heart failure. NEJM, 1987; 316: 1429-1435.
10. CIBIS-II Investigators. The cardiac Insufficiency Bisoprolol Study II. Lancet, 1999; 353: 9-13.
11. Packer M, Coats A and Fowler M et al. COPERNICUS: Effect of carvedilol on survival in severe chronic heart failure. NEJM, 2001; 344: 1651-1658.
12. The MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalization, and well being in patients with heart failure. JAMA, 2000; 283: 1295-1302.
13. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 1999; 341: 709.
14. Albouaini K, Egred M, Rao A, Alahmar A, Wright DJ. Cardiac resynchronisation therapy: evidence based benefits and patient selection. Eur J Intern Med, 2008; 19: 165-172.
15. Khand A, Gemmel I, Clark AL, Cleland JG. Is the prognosis of heart failure improving? J Am Coll Cardiol, 2000; 36: 2284-2286.
16. Baldasseroni S, Opasich C, Gorini M et al. Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure. Am Heart J, 2002; 143: 398-405.
17. Auricchio A, Abraham WT. Cardiac resynchronization therapy: Current state of the art. Cost versus benefit. Circulation, 2004; 109: 300-307.
18. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med, 2001; 344: 873-880.
19. Leclercq C, Walker S, Linde C et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J, 2002; 23: 1780-1787.
20. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med, 2002; 346: 1845-1853.
21. Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol, 2003; 42: 1454-1459.
22. Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA, 2003; 289: 2685-2694.
23. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004; 350: 2140-2150.
24. Cleland JGF, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005; 352: 1539-1549.
25. Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol, 2002; 39: 2026-2033.
26. Auricchio A, Ding J, Spinelli JC et al. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol, 2002; 39: 1163-1169.
27. Blanc JJ, Etienne Y, Gilard M et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation, 1997; 96: 3273-3277.
28. Auricchio A, Stellbrink C, Block M et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure study group. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation, 1999; 99: 2993-3001.
29. Saxon LA, Kerwin WF, Cahalan MK et al. Acute effects of intra-operative multisite ventricular pacing on LV function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol, 1998; 9: 13-21.
30. Kass DA, Chen CH, Curry C et al. Improved LV mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation, 1999; 99: 1567-1573.
31. Toussaint JF, Lavergne T, Ollitraut J et al. Biventricular pacing in severe heart failure patients reverses electromechanical dyssynchronization from apex to base. Pacing Clin Electrophysiol, 2000; 23 (11 Pt 2): 1731-1734.
32. Barold H. Preliminary clinical review of Medtronic's InSync MIRACLE PMA (Report; http://www.fda.gov/cdrh/pdf/p010015.html; 26 September 2005).
33. Bradley DJ, Bradley EA, Baughman KL et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA, 2003; 289: 730-740.
34. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J, 2006; 2: 2682-2688.
35. McAlister FA, Ezekowitz JA, Wiebe N et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med, 2004; 141: 381-390.
36. McAlister FA, Ezekowitz J, Hooton N et al. Cardiac resynchronization therapy for patients with LV systolic dysfunction: A systematic review. JAMA, 2007; 297: 2502-2514.
37. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2008; 117: e350-e408.
38. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol, 2006; 21: 20-26.
39. Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol, 2007; 100: 1665-1670.
40. Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of LV systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart, 2003; 89: 54-60.
41. Bax JJ, Bleeker GB, Marwick TH et al. LV dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol, 2004; 44: 1834-1840.
42. Pitzalis MV, Iacoviello M, Romito R et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol, 2005; 45: 65-69.
43. Bleeker GB, Schalij MJ, Molhoek SG et al. Frequency of LV dyssynchrony in patients with heart failure and a narrow QRS complex. Am J Cardiol, 2005; 95: 140-142.
44. Diaz-Infante E, Mont L, Leal J et al. SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol, 2005; 95: 1436-1440.
45. Buch E, Lellouche N, De Diego C et al. Left ventricular apical wall motion abnormality is associated with lack of response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy. Heart Rhythm, 2007; 4: 1300-1305.
46. Achilli A, Sassara M, Ficili S et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol, 2003; 42: 2117-2124.
47. Bleeker GB, Holman ER, Steendijk P et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol, 2006; 48: 2243-2250.
48. Yu CM, Chan YS, Zhang Q et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol, 2006; 48: 2251-2257.
49. Gasparini M, Regoli F, Galimberti P et al. Three years of cardiac resynchronization therapy: Could superior benefits be obtained in patients with heart failure and narrow QRS? Pacing Clin Electrophysiol, 2007; 30 (Suppl. 1): S34-S39.
50. Turner MS, Bleasdale RA, Vinereanu D et al. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing, Circulation, 2004; 109: 2544-2549.
51. Gasparini M, Mantica M, Galimberti P et al. Beneficial effects of biventricular pacing in patients with a "narrow" QRS. Pacing Clin Electrophysiol, 2005; 28: 357-360.
52. Yu CM, Fung JW, Chan CK et al. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol, 2004; 15: 1058-1065.
53. Turner MS, Bleasdale RA, Mumford CE, Frenneaux MP, Morris-Thurgood JA LV pacing improves haemodynamic variables in patients with heart failure with a normal QRS duration. Heart, 2004; 90: 502-505.
54. Jeevanantham V, Zareba W, Navaneethan S et al. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J, 2008; 15: 230-236.
55. Beshai JF, Grimm RA, Nagueh SF et al. RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med, 2007; 357: 2461-2671.
56. http://www.escardio.org/bodies/associations/EHRA/news/ Clinical-trial-Cardiac-Resynchronization-Therapy.htm.
57. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) Trial. Large prospective clinical trial evaluating mechanical dyssynchrony parameters as predictive of CRT response. Circulation, 2008; 117: 2608-2616.
58. Gorcsan Jr, Kanzaki H, Bazaz R, Dohi K, Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol, 2004; 93: 1178-1181.
59. Yu CM, Fung JW, Zhang Q et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation, 2004; 110: 66-73.
60. Abraham J, Abraham TP. Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Cardiovascular Imaging. Circulation, 2008; 1: 79-85.
61. Landolina M, Lunati M, Gasparini M et al.; InSync/InSync ICD Italian Registry Investigators. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Am J Cardiol, 2007; 100: 1007-1012.
62. Moss AJ, Brown MW, Cannom DS et al.. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol, 2005; 10 (suppl. 4): 34-43.
63. Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic LV Dysfunction (REVERSE) study. Congest Heart Fail, 2008; 14: 66-74.
64. http://acc08.acc.org/SSN/Pages/ScientificSessionNews-Preview3.aspx#item1.
65. Daubert JC, Ritter P, Le Breton H et al. Permanent LV pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol, 1998; 21 (1 Part 2): 239-245.
66. Doll N, Piorkowski C, Czesla M, et al. Epicardial versus transvenous LV lead placement in patients receiving cardiac resynchronization therapy: Results from a randomized prospective study. Thoracic Cardiovasc Surg, 2008; 56: 256-261.
67. Mair H, Jansens JL, Lattouf OM et al. Epicardial lead implantation techniques for biventricular pacing via left lateral mini-thoracotomy, video-assisted thoracoscopy and robotic approach. Heart Surg Forum, 2003; 6: 412-417.
68. Izutani H, Quan KJ, Biblo LA et al. Biventricular pacing for congestive heart failure: early experience in surgical epicardial versus coronary sinus lead placement. Heart Surg Forum, 2002; 6: E1-E6.
69. Atoui R, Essebag V, We V, Ge Y, Auclair MH, Hadjis T, Shum-Tim D. Biventricular pacing for end-stage heart failure: Early experience in surgical versus transvenous LV lead placement. Interact Cardiovasc Thorac Surg, 2008; 9.
70. Kies P, Leclercq C, Bleeker GB et al. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart, 2006; 92: 490-494.
71. Linde C, Leclercq C, Rex S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol, 2002; 40: 111-118.
72. Molhoek SG, Bax JJ, Bleeker GB et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol, 2004; 94: 1506-1509.
73. Buck S, Rienstra M, Maass AH, Nieuwland W, Van Veldhuisen DJ, Van Gelder IC. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: Importance of new-onset atrial fibrillation and total atrial conduction time. Europace, 2008; 10: 558-565.
74. Gasparini M, Auricchio A, Regoli F et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol, 2006; 48: 734-743.
75. Auricchio A, Prinzen FW. Cardiac resynchronization therapy: The more pacing sites, the better the outcome? J Am Coll Cardiol, 2008; 51: 1463-1465.
76. Leclercq C, Gadler F, Kranig W et al; TRIP-HF (Triple Resynchronization In Paced Heart Failure Patients) Study Group. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol, 2008; 51: 1455-1462.